Institute Of Clinical Hypnosis And Related Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -23.92%
(FY 2023)
- Profit -339.46%
(FY 2023)
- Ebitda -182.14%
(FY 2023)
- Net Worth -40.75%
(FY 2023)
- Total Assets 85.49%
(FY 2023)
About Institute Of Clinical Hypnosis And Related Sciences
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Shah and Misba Shah serve as directors at the Company.
- CIN/LLPIN
U80904MH2012PTC231467
- Company No.
231467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Institute Of Clinical Hypnosis And Related Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Misba Shah  | Director | 25-May-2012 | Current |
| Anita Shah | Director | 25-May-2012 | Current |
Financial Performance of Institute Of Clinical Hypnosis And Related Sciences.
Institute Of Clinical Hypnosis And Related Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.92% decrease. The company also saw a substantial fall in profitability, with a 339.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Institute Of Clinical Hypnosis And Related Sciences?
Unlock access to Institute Of Clinical Hypnosis And Related Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Institute Of Clinical Hypnosis And Related Sciences?
Unlock and access historical data on people associated with Institute Of Clinical Hypnosis And Related Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Clinical Hypnosis And Related Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Clinical Hypnosis And Related Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
